Akonni Biosystems, Inc. – Trademark Portfolio
Entity Type: 03
Akonni Biosystems, Inc. owns a portfolio of 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as TRUDX, TRUTIP, TRUARRAY, TRUDIAGNOSIS, and AKONNI BIOSYSTEMS. Of these, 5 are registered. The portfolio spans 4 Nice Classification classes, led by Class 9 (Computers & Electronics) and Class 10 (Medical Apparatus). Headquartered in Frederick, MD.
400 Sagner Avenue, Suite 300
Frederick, MD 21701
Showing of trademarks Trademarks
Trademark Classifications
Akonni Biosystems, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Akonni Biosystems, Inc. have?
Akonni Biosystems, Inc. has 9 U.S. trademarks filed with the USPTO. Of these, 5 registered, 3 abandoned, 1 cancelled.
What trademark classes does Akonni Biosystems, Inc. file in?
Akonni Biosystems, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Akonni Biosystems, Inc.'s most well-known trademarks?
Akonni Biosystems, Inc.'s registered trademark portfolio includes well-known marks such as TRUDX, TRUTIP, TRUARRAY, TRUDIAGNOSIS, and AKONNI BIOSYSTEMS. These are among 5 currently registered trademarks in the portfolio.
What is Akonni Biosystems, Inc.'s trademark registration success rate?
Akonni Biosystems, Inc. has a 56% trademark registration rate, with 5 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.